The rate of cardiac injury as determined by cTnI in this study was 19%. In trying to identify any factors that may contribute to an overestimation of cardiac injury, we consider the use of cTnI ...

Elevated levels of cardiac troponin are associated with an increased risk of adverse cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes (ACS), but might not ...

According to a new market research report titled, 'Cardiac Biomarkers Market Size, Share, Forecast, & Trends Analysis by Type ...

Polymedco has received 510(k) clearance from the US Food and Drug Administration (FDA) for its rapid troponin assay as part of its Pathfast Biomarker Analyser. The troponin assay (hs-CTnl-II ...

More information: Gyeo‐Re Han et al, Deep Learning‐Enhanced Chemiluminescence Vertical Flow Assay for High‐Sensitivity ...

Cardiac enzymes ― also known as cardiac biomarkers ― include myoglobin, troponin and creatine kinase. Historically, lactate dehydrogenase, or LDH, was also used but is non-specific.

Interested parties may access the live webcast of the fireside chat by visiting the Investors & Media section of the Cytokinetics website at https://www.cytokinetics.com. The webcast replay will be ...

evidence of increased filling pressures or risk factors plus increased levels of BNPs or persistently elevated cardiac troponin Stage C: Structural heart disease with prior or current symptoms of ...

Labs are essential for precise testing and complex analysis, managing multi-marker panels (e.g., BNP, CK-MB, myoglobin, and troponin) to provide a comprehensive view of cardiac health. The global ...

According to a new market research report titled, 'Cardiac Biomarkers Market Size, Share, Forecast, & Trends Analysis by Type (Troponin, CK-MB ...